Zambales inches closer to 400,000 jab target with 11,000 fully vaccinated | Inquirer News

Zambales inches closer to 400,000 jab target with 11,000 fully vaccinated

Health workers go to remote areas in Subic town, Zambales province to administer vaccines against COVID-19 to priority residents. (Photo courtesy of Subic municipal health office)

SAN ANTONIO, Zambales—At least 11,214 residents were already fully vaccinated against SARS Cov2, the virus that causes COVID-19, according to the province’s top health official.

The number included at least 277 more individuals who got the second dose on Thursday (July 1).

Article continues after this advertisement

Dr. Noel Bueno, provincial health director, said at least 984 residents were also given their first dose of the vaccine on the same day.

FEATURED STORIES

So far, at least 31,699 residents had already received their first dose of the vaccine.

The province administered a total of 42,913 doses to residents on the list of priority groups like health workers, senior citizens and those with comorbidities, or preexisting health conditions.

Article continues after this advertisement

Health workers administered 16,556 AstraZeneca (Oxford) vaccines and 26,357 Coronavac (Sinovac) vaccines.

Article continues after this advertisement

The province needs to vaccinate 400,000 of its 590,800 residents, or 70 percent of the population, to achieve herd immunity.

TSB

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: AstaZeneca, pandemic, Sinovac

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.